Literature DB >> 14972097

Metabolic syndrome X: an inflammatory condition?

Undurti N Das1.   

Abstract

Obesity, atherosclerosis, insulin resistance and hyperinsulinemia, hyperlipidemia, essential hypertension, type 2 diabetes mellitus, and coronary heart disease (CHD) are the components of metabolic syndrome X and are associated with elevated plasma levels of C-reactive protein, interleukin-6, and tumor necrosis factor-alpha, which are markers of inflammation. This suggests that metabolic syndrome X is a low-grade, systemic, inflammatory condition. Hence, instituting anti-inflammatory measures might be beneficial in preventing or halting the progress of metabolic syndrome X in high-risk populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14972097     DOI: 10.1007/s11906-004-0014-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  67 in total

1.  Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

Authors:  J M Fernandez-Real; M Vayreda; C Richart; C Gutierrez; M Broch; J Vendrell; W Ricart
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

2.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

Review 3.  The role of TNFalpha and TNF receptors in obesity and insulin resistance.

Authors:  G S Hotamisligil
Journal:  J Intern Med       Date:  1999-06       Impact factor: 8.989

4.  Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.

Authors:  Simin Liu; JoAnn E Manson; Julie E Buring; Meir J Stampfer; Walter C Willett; Paul M Ridker
Journal:  Am J Clin Nutr       Date:  2002-03       Impact factor: 7.045

5.  Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia.

Authors:  J P Kirwan; R K Krishnan; J A Weaver; L F Del Aguila; W J Evans
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-12       Impact factor: 4.310

6.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

7.  Weight loss in combination with physical activity improves endothelial dysfunction in human obesity.

Authors:  Angela Sciacqua; Mafalda Candigliota; Roberto Ceravolo; Angela Scozzafava; Flora Sinopoli; Andrea Corsonello; Giorgio Sesti; Francesco Perticone
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

8.  Adiponectin and protection against type 2 diabetes mellitus.

Authors:  Joachim Spranger; Anja Kroke; Matthias Möhlig; Manuela M Bergmann; Michael Ristow; Heiner Boeing; Andreas F H Pfeiffer
Journal:  Lancet       Date:  2003-01-18       Impact factor: 79.321

9.  Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.

Authors:  Philip A Kern; Gina B Di Gregorio; Tong Lu; Negah Rassouli; Gouri Ranganathan
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

10.  Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects.

Authors:  F Corica; A Allegra; A Corsonello; M Buemi; G Calapai; A Ruello; V Nicita Mauro; D Ceruso
Journal:  Int J Obes Relat Metab Disord       Date:  1999-04
View more
  18 in total

Review 1.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

2.  [Chronic spontaneous urticaria : A disease of civilization?]

Authors:  E Makrantonaki
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

3.  A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease.

Authors:  Undurti N Das
Journal:  World J Diabetes       Date:  2011-11-15

4.  Is Aortic Aneurysm Preventable?

Authors:  Undurti N Das
Journal:  J Transl Int Med       Date:  2017-06-30

5.  Diet, exercise and the metabolic syndrome.

Authors:  Christos Pitsavos; Demosthenes Panagiotakos; Michael Weinem; Christodoulos Stefanadis
Journal:  Rev Diabet Stud       Date:  2006-11-10

6.  Metabolic syndrome in the offspring of centenarians: focus on prevalence, components, and adipokines.

Authors:  R Ostan; L Bucci; E Cevenini; M G Palmas; E Pini; M Scurti; R Vescovini; C Caruso; D Mari; G Vitale; C Franceschi; D Monti
Journal:  Age (Dordr)       Date:  2012-11-09

7.  Relationships between inflammation, adiponectin, and oxidative stress in metabolic syndrome.

Authors:  Shu-Ju Chen; Chi-Hua Yen; Yi-Chia Huang; Bor-Jen Lee; Simon Hsia; Ping-Ting Lin
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

8.  The interleukin-6 and noradrenaline mediated inflammation-stress feedback mechanism is dysregulated in metabolic syndrome: effect of exercise.

Authors:  Leticia Martín-Cordero; Juan J García; Maria D Hinchado; Eduardo Ortega
Journal:  Cardiovasc Diabetol       Date:  2011-05-20       Impact factor: 9.951

9.  Innate immunity and inflammation in ageing: a key for understanding age-related diseases.

Authors:  Federico Licastro; Giuseppina Candore; Domenico Lio; Elisa Porcellini; Giuseppina Colonna-Romano; Claudio Franceschi; Calogero Caruso
Journal:  Immun Ageing       Date:  2005-05-18       Impact factor: 6.400

Review 10.  Inflammation--a lifelong companion. Attempt at a non-analytical holistic view.

Authors:  M Ferencík; V Stvrtinová; I Hulín; M Novák
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.